Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role

Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role

Source: 
Fierce Biotech
snippet: 

Biohaven Pharmaceutical is eyeing filing for approval early next year for its experimental pain spray after new data showed it hit its primary endpoints in a phase 3 test.